Potential new targets involved in 1,3-dinitrobenzene induced testicular toxicity

Toxicology Letters

Volumn 213, Issue 2, 2012, Pages 275-284

  Ludwig, Sophie ^a,c   Tinwell, Helen ^a   Rouquié, David ^a   Schorsch, Frédéric ^a   Pallardy, Marc ^b   Bars, Rémi ^a  

^a BAYER AG   (Germany)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

1,3 Dinitrobenzene; Steroidogenesis; Testicular toxicity; Toxicogenomics

Indexed keywords

1,3 DINITROBENZENE; ESTRADIOL; POLO LIKE KINASE; PROGESTERONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; GENE EXPRESSION PROFILING; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; SINGLE DRUG DOSE; STEROIDOGENESIS; TESTIS INJURY; TESTOSTERONE BLOOD LEVEL; TRANSCRIPTOMICS;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DINITROBENZENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GENE EXPRESSION PROFILING; HUMANS; MALE; PROGESTERONE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SERTOLI CELLS; TESTIS; TESTOSTERONE;

RATTUS; RODENTIA;

EID: 84864480974     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.07.010     Document Type: Article

References (44)

1. Amin R.P., Vickers A.E., Sistare F., Thompson K.L., Roman R.J., Lawton M., Kramer J., Hamadeh H.K., Collins J., Grissom S., Bennett L., Tucker C.J., Wild S., Kind C., Oreffo V., Davis J.W., Curtiss S., Naciff J.M., Cunningham M., Tennant R., Stevens J., Car B., Bertram T.A., Afshari C.A. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 2004, 112:465-479.
2. Barr F.A., Sillje H.H., Nigg E.A. Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 2004, 5:429-440.
3. Bars R., Broeckaert F., Fegert I., Gross M., Hallmark N., Kedwards T., Lewis D., O'Hagan S., Panter G.H., Weltje L., Weyers A., Wheeler J.R., Galay-Burgos M. Science based guidance for the assessment of endocrine disrupting properties of chemicals. Regul. Toxicol. Pharmacol. 2011, 59:37-46.
4. Blackburn D.M., Gray A.J., Lloyd S.C., Sheard C.M., Foster P.M. A comparison of the effects of the three isomers of dinitrobenzene on the testis in the rat. Toxicol. Appl. Pharmacol. 1988, 92:54-64.
5. Blomme E.A., Yang Y., Waring J.F. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol. Lett. 2009, 186:22-31.
6. Cody T.E., Witherup S., Hastings L., Stemmer K., Christian R.T. 1,3-Dinitrobenzene: toxic effects in vivo and in vitro. J. Toxicol. Environ. Health 1981, 7:829-847.
7. Council NR Guide for the Care and Use of Laboratory Animals 1996, National Academies Press, Washington, DC.
8. Cui Y., Paules R.S. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 2010, 11:573-585.
9. Daston G.P. Gene expression, dose-response, and phenotypic anchoring: applications for toxicogenomics in risk assessment. Toxicol. Sci. 2008, 105:233-234.
10. Davis R.O., Gravance C.G., Thal D.M., Miller M.G. Automated analysis of toxicant-induced changes in rat sperm head morphometry. Reprod. Toxicol. 1994, 8:521-529.
11. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.J. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 2004, 77:19-34.
12. Foster P.M., Lloyd S.C., Prout M.S. Toxicity and metabolism of 1,3-dinitrobenzene in rat testicular cell cultures. Toxicol. In Vitro 1987, 1:31-37.
13. Glover D.M., Hagan I.M., Tavares A.A. Polo-like kinases: a team that plays throughout mitosis. Genes Dev. 1998, 12:3777-3787.
14. Gracia T., Hilscherova K., Jones P.D., Newsted J.L., Zhang X., Hecker M., Higley E.B., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. The H295R system for evaluation of endocrine-disrupting effects. Ecotoxicol. Environ. Saf. 2006, 65:293-305.
15. Hecker M., Hollert H., Cooper R., Vinggaard A.M., Akahori Y., Murphy M., Nellemann C., Higley E., Newsted J., Laskey J., Buckalew A., Grund S., Maletz S., Giesy J., Timm G. The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study. Environ. Sci. Pollut. Res. Int. 2011, 18:503-515.
16. Hecker M., Newsted J.L., Murphy M.B., Higley E.B., Jones P.D., Wu R., Giesy J.P. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Toxicol. Appl. Pharmacol. 2006, 217:114-124.
17. Heinloth A.N., Irwin R.D., Boorman G.A., Nettesheim P., Fannin R.D., Sieber S.O., Snell M.L., Tucker C.J., Li L., Travlos G.S., Vansant G., Blackshear P.E., Tennant R.W., Cunningham M.L., Paules R.S. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 2004, 80:193-202.
18. Hess R.A., Linder R.E., Strader L.F., Perreault S.D. Acute effects and long-term sequelae of 1,3-dinitrobenzene on male reproduction in the rat. II. Quantitative and qualitative histopathology of the testis. J. Androl. 1988, 9:327-342.
19. Irimura K., Yamaguchi M., Morinaga H., Sugimoto S., Kondou Y., Koida M. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 26. Detection of 1,3-dinitrobenzene-induced histopathological changes in testes and epididymides of rats with 2-week daily repeated dosing. J. Toxicol. Sci. 2000, 25:251-258.
20. Jurewicz J., Hanke W., Radwan M., Bonde J.P. Environmental factors and semen quality. Int. J. Occup. Med. Environ. Health 2009, 22:305-329.
21. Kennel P.F., Pallen C.T., Bars R.G. Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens). Reprod. Toxicol. 2004, 18:63-73.
22. Lee Y.S., Yoon H.J., Oh J.H., Park H.J., Lee E.H., Song C.W., Yoon S. 1,3-Dinitrobenzene induces apoptosis in TM4 mouse Sertoli cells: involvement of the c-Jun N-terminal kinase (JNK) MAPK pathway. Toxicol. Lett. 2009, 189:145-151.
23. Linder R.E., Hess R.A., Perreault S.D., Strader L.F., Barbee R.R. Acute effects and long-term sequelae of 1,3-dinitrobenzene on male reproduction in the rat. I. Sperm quality, quantity, and fertilizing ability. J. Androl. 1988, 9:317-326.
24. Ludwig S., Tinwell H., Schorsch F., Cavaille C., Pallardy M., Rouquie D., Bars R. A molecular and phenotypic integrative approach to identify a no-effect dose level for antiandrogen-induced testicular toxicity. Toxicol. Sci. 2011, 122:52-63.
25. Main K.M., Skakkebaek N.E., Virtanen H.E., Toppari J. Genital anomalies in boys and the environment. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:279-289.
26. Matsui H., Takahashi M. A novel quantitative morphometry of germ cells for the histopathological evaluation of rat testicular toxicity. J. Toxicol. Sci. 1999, 24:17-25.
27. Matsuyama T., Niino N., Kiyosawa N., Teranishi M., Sanbuissho A. Toxicogenomic investigation on rat testicular toxicity elicited by 1,3-dinitrobenzene. Toxicology 2011, 290:169-177.
28. Moore N.P., Creasy D.M., Gray T.J., Timbrell J.A. Urinary creatine profiles after administration of cell-specific testicular toxicants to the rat. Arch. Toxicol. 1992, 66:435-442.
29. Muguruma M., Yamazaki M., Okamura M., Moto M., Kashida Y., Mitsumori K. Molecular mechanism on the testicular toxicity of 1,3-dinitrobenzene in Sprague-Dawley rats: preliminary study. Arch. Toxicol. 2005, 79:729-736.
30. Nigg E.A. Polo-like kinases: positive regulators of cell division from start to finish. Curr. Opin. Cell Biol. 1998, 10:776-783.
31. Omura T., Morohashi K. Gene regulation of steroidogenesis. J. Steroid Biochem. Mol. Biol. 1995, 53:19-25.
32. Reader S.C., Shingles C., Stonard M.D. Acute testicular toxicity of 1,3-dinitrobenzene and ethylene glycol monomethyl ether in the rat: evaluation of biochemical effect markers and hormonal responses. Fundam. Appl. Toxicol. 1991, 16:61-70.
33. Rehnberg G.L., Linder R.E., Goldman J.M., Hein J.F., McElroy W.K., Cooper R.L. Changes in testicular and serum hormone concentrations in the male rat following treatment with m-dinitrobenzene. Toxicol. Appl. Pharmacol. 1988, 95:255-264.
34. Rouquie D., Friry-Santini C., Schorsch F., Tinwell H., Bars R. Standard and molecular NOAELs for rat testicular toxicity induced by flutamide. Toxicol. Sci. 2009, 109:59-65.
35. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16:972-978.
36. Stephen E.H., Chandra A. Declining estimates of infertility in the United States: 1982-2000. Fertil. Steril. 2006, 86:516-523.
37. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 2001, 63:193-213.
38. Strandgaard C., Miller M.G. Germ cell apoptosis in rat testis after administration of 1,3-dinitrobenzene. Reprod. Toxicol. 1998, 12:97-103.
39. Suter L., Babiss L.E., Wheeldon E.B. Toxicogenomics in predictive toxicology in drug development. Chem. Biol. 2004, 11:161-171.
40. Tengowski M.W., Feng D., Sutovsky M., Sutovsky P. Differential expression of genes encoding constitutive and inducible 20S proteasomal core subunits in the testis and epididymis of theophylline- or 1,3-dinitrobenzene-exposed rats. Biol. Reprod. 2007, 76:149-163.
41. Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., Guillette L.J., Jegou B., Jensen T.K., Jouannet P., Keiding N., Leffers H., McLachlan J.A., Meyer O., Muller J., Rajpert-De Meyts E., Scheike T., Sharpe R., Sumpter J., Skakkebaek N.E. Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. 1996, 104(Suppl. 4):741-803.
42. van Vugt M.A., Medema R.H. Getting in and out of mitosis with Polo-like kinase-1. Oncogene 2005, 24:2844-2859.
43. Williams J., Foster P.M. The production of lactate and pyruvate as sensitive indices of altered rat Sertoli cell function in vitro following the addition of various testicular toxicants. Toxicol. Appl. Pharmacol. 1988, 94:160-170.
44. Yang Y., Blomme E.A., Waring J.F. Toxicogenomics in drug discovery: from preclinical studies to clinical trials. Chem. Biol. Interact. 2004, 150:71-85.